Chronic myelogenous leukemia molecular signature. (Q47821781)

5 February 2018

title

Chronic myelogenous leukemia molecular signature. (English)

1 reference

5 February 2018

1 reference

Michal Oskar Nowicki

1

1 reference

5 February 2018

Peter Pawlowski

2

1 reference

5 February 2018

Thomas Fischer

3

1 reference

5 February 2018

Georg Hess

4

1 reference

5 February 2018

Tomasz Pawlowski

5

1 reference

5 February 2018

Tomasz Skorski

6

1 reference

5 February 2018

publication date

1 June 2003

1 reference

5 February 2018

language of work or name

0 references

1 reference

5 February 2018

volume

22

1 reference

5 February 2018

issue

25

1 reference

5 February 2018

page(s)

3952-3963

1 reference

5 February 2018

Signaling by ABL oncogenes through cyclin D1.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

c-Myc target genes involved in cell growth, apoptosis, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Translational control of the proteome: Relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Molecular genetic advances in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

The reciprocal role of Egr-1 and Sp family proteins in regulation of the PTP1B promoter in response to the p210 Bcr-Abl oncoprotein-tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Does the bcr/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Formation of spindle poles by dynein/dynactin-dependent transport of NuMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Multiclass cancer diagnosis using tumor gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Mechanisms of transformation by the BCR/ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Dominant negative MYC blocks transformation by ABL oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Waiting for anaphase: Mad2 and the spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Oncogenic tyrosine kinases and the DNA-damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

CIS1, a cytokine-inducible SH2 protein, suppresses BCR/ABL-mediated transformation. Involvement of the ubiquitin proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Overexpression of activin A in stage IV colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Interleukin-8 and human cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Signaling pathways activated by oncogenic forms of Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

Systemic infection due to atypical mycobacteria in patients with chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

inferred from DOI database lookup

7 January 2021

based on heuristic

Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

inferred from DOI database lookup

7 January 2021

based on heuristic

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206620

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1206620

1 reference

5 February 2018

1 reference

5 February 2018